Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Human Immunodeficiency Virus | Research article

The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men

Authors: Wei Luo, Vickie Sullivan, Pollyanna R. Chavez, Sarah E. Wiatrek, Maria Zlotorzynska, Amy Martin, Rebecca Rossetti, Travis Sanchez, Patrick Sullivan, Robin J. MacGowan, S. Michele Owen, Silvina Masciotra

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

In the US, one in six men who have sex with men (MSM) with HIV are unaware of their HIV infection. In certain circumstances, access to HIV testing and viral load (VL) monitoring is challenging. The objective of this study was to evaluate the feasibility of conducting laboratory-based HIV and antiretroviral (ARV) drug testing, and VL monitoring as part of two studies on self-collected dried blood spots (DBS).

Methods

Participants were instructed to collect DBS by self-fingerstick in studies that enrolled MSM online. DBS from the first study (N = 1444) were tested with HIV serological assays approved by the Food and Drug Administration (FDA). A subset was further tested with laboratory-modified serological and VL assays, and ARV levels were measured by mass spectrometry. DBS from the second study (N = 74) were only tested to assess VL monitoring.

Results

In the first study, the mail back rate of self-collected DBS cards was 62.9%. Ninety percent of DBS cards were received at the laboratory within 2 weeks from the day of collection, and 98% of the cards had sufficient spots for one assay. Concordance between FDA-approved and laboratory-modified protocols was high. The samples with undetectable ARV had higher VL than samples with at least one ARV drug. In the second study, 70.3% participants returned self-collected DBS cards, and all had sufficient spots for VL assay. High VL was observed in samples from participants who reported low ARV adherence.

Conclusions

In these studies, MSM were able to collect and provide adequate DBS for HIV testing. The FDA-approved and laboratory-modified testing algorithms performed similarly. DBS collected at home may be feasible for HIV testing, ARV measurement, and monitoring viral suppression.
Literature
2.
go back to reference Centers for Disease Control and Prevention. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men-United States. 2017. Centers for Disease Control and Prevention. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men-United States. 2017.
6.
go back to reference Chavez PR, Wesolowski LD, Owen SM, Gravens L, Sullivan P, MacGowan RJ. Perceptions and performance of self-administrated rapid HIV tests conducted by untrained users in real world settings. Atlanta: Oral presentation at HIV Diagnostics Conference; 2016. p. 21–4. Chavez PR, Wesolowski LD, Owen SM, Gravens L, Sullivan P, MacGowan RJ. Perceptions and performance of self-administrated rapid HIV tests conducted by untrained users in real world settings. Atlanta: Oral presentation at HIV Diagnostics Conference; 2016. p. 21–4.
7.
go back to reference Sanchez TH, Sineath RC, Kahle EM, Tregear SJ, Sullivan P. The annual American men's internet survery of behaviors of men who have sex woth men in the United States: protocol and key indicators report 2013. JMIR Public Health Surveill. 2015;1(1):1–15.CrossRef Sanchez TH, Sineath RC, Kahle EM, Tregear SJ, Sullivan P. The annual American men's internet survery of behaviors of men who have sex woth men in the United States: protocol and key indicators report 2013. JMIR Public Health Surveill. 2015;1(1):1–15.CrossRef
9.
go back to reference Avioq, Inc. Avioq HIV-1 Microelisa system package insert. 2009. Avioq, Inc. Avioq HIV-1 Microelisa system package insert. 2009.
10.
go back to reference Bio-Rad Laboratories. GS HIV-1 Western Blot Package insert. 2012. Bio-Rad Laboratories. GS HIV-1 Western Blot Package insert. 2012.
14.
go back to reference Hirshfield S, Teran RA, Downing MJ, Chiasson MA, Tieu H, Dize CA, et al. Quantification of HIV-1 RNA among men who have sex with men using an at-home self-collected dried blood spot specimen: feasibility study. JMIR Public Health and Surveill. 2018;4(4):e10847. https://doi.org/10.2196/10847.CrossRef Hirshfield S, Teran RA, Downing MJ, Chiasson MA, Tieu H, Dize CA, et al. Quantification of HIV-1 RNA among men who have sex with men using an at-home self-collected dried blood spot specimen: feasibility study. JMIR Public Health and Surveill. 2018;4(4):e10847. https://​doi.​org/​10.​2196/​10847.CrossRef
17.
go back to reference Manak M, Hack HR, Shutt AL, Danboise BA, Jagodzinski LL, Peel SA. Stability of human immunodeficiency virus serology markers in sample collected as HemaSpot and Whatman903 dried blood spots. J Clin Microbiol. 2018;56(10):e00933–18.CrossRef Manak M, Hack HR, Shutt AL, Danboise BA, Jagodzinski LL, Peel SA. Stability of human immunodeficiency virus serology markers in sample collected as HemaSpot and Whatman903 dried blood spots. J Clin Microbiol. 2018;56(10):e00933–18.CrossRef
Metadata
Title
The feasibility of modified HIV and antiretroviral drug testing using self-collected dried blood spots from men who have sex with men
Authors
Wei Luo
Vickie Sullivan
Pollyanna R. Chavez
Sarah E. Wiatrek
Maria Zlotorzynska
Amy Martin
Rebecca Rossetti
Travis Sanchez
Patrick Sullivan
Robin J. MacGowan
S. Michele Owen
Silvina Masciotra
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06110-x

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue